The importance of pharmaceutical innovation in Europe cannot be underestimated. The pharma industry is one of Europe’s top-performing high-technology sectors. It contributes around €175B to the EU’s trade balance – a tenfold rise over the last two decades. Despite what seems like encouraging progress, the more recent trends in Europe should be setting alarm bells...
Tag: Patients
Post
Post
Europe’s health resilience relies on its ability to innovate
In the face of continued global geopolitical uncertainty, Europe is paying increasing attention to its sovereignty, security and resilience. The availability of critical medicines and vaccines is central to Europe’s health preparedness. As governments across Europe rebuild and learn from the pandemic, the policies that can build health resilience and strengthen health systems are in...
Post
Experienced trippers should advise on Europe’s use of psychedelics, says lobby
Europe needs a collective voice of authority on the medical use of psychedelics — and experienced users should be on that panel — according to a lobby group for developers and those working in the field. In a briefing document to be sent to the European Medicines Agency (EMA) on Tuesday, and seen by POLITICO,...
Post
After a 70-year wait, will Europe’s new patent system be a total flop?
Will it be worth the wait? Seventy years since the idea was first mooted — pre-dating the EU’s three institutions — a new European patent system launches on June 1. It’s designed as a one-stop shop, providing inventors with a single patent that protects their inventions in multiple EU countries and establishing a single Unified...
Post
Pfizer, the EU, and disappearing ink
Press play to listen to this article Voiced by artificial intelligence. It’s as if Pfizer’s massive COVID-19 vaccine deal with the European Commission were written with disappearing ink: the more time passes, the more details seem to vanish. For a while now controversy has raged around the text messages supposedly exchanged between Commission President Ursula...
Post
EU and Pfizer renegotiate controversial vaccine contract
The European Commission and U.S. pharmaceutical giant Pfizer have renegotiated a massive contract for COVID-19 vaccine doses that the EU entered into at the height of the pandemic. The Commission announced that the two parties had agreed Pfizer would spread out deliveries over the course of the next four years, into 2027, and to reduce...
Post
Big Pharma meets its match as EU refuses to budge
The European Union is set for a showdown with the pharma industry. Brussels held firm on a planned overhaul of its pharmaceutical rules on Wednesday, confirming a punishing new measure that will cut into the sector’s bottom line. The proposed rules would remove two years of data protection from all new medicines launched in the...
Post
The real reason Europe’s medicines industry is dying
Press play to listen to this article Voiced by artificial intelligence. The European pharmaceutical sector is screaming bloody murder. The crime? An overhaul of the European Union’s pharmaceutical rules, published Wednesday, in which the European Commission plans to cut into industry’s profits in a bid to improve access to medicines throughout the bloc. Industry execs...
Post
Why Europe needs a bold vision in the fight against cancer
Fewer than 10 percent of the global population lives in Europe, but it has a quarter of all cancer cases in the world. The overall economic impact of cancer in the region is estimated at €100bn each year, meaning this disease not only takes lives but has significant consequences for economies and societies. Optimal treatment...
Post
Europe’s TB deaths rise for first time in 2 decades
Tuberculosis (TB) deaths in Europe increased in 2021 for the first time in nearly two decades due to the pandemic’s disruption on treatment and diagnostic services, the European Centre for Disease Prevention and Control (ECDC) and the World Health Organization’s Europe office said today. In the WHO European Region, 27,300 people died from TB in...